On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma Post author:Sam Post published:November 16, 2017 Post category:BioPharma Genentech scored two approvals from the FDA this week. Source: BioSpace You Might Also Like PE Firm in Talks to Buy VWR in Deal Worth $5 Billion May 3, 2017 Argenx To Host Conference Call & Webcast To Report Second Quarter Business Update And Half Year 2017 Financial Results On August 24, 2017 August 16, 2017 Certara Corporation Releases New Version Of D360, Its Industry-Leading Informatics Platform For Pharma Discovery Scientists January 30, 2017
Argenx To Host Conference Call & Webcast To Report Second Quarter Business Update And Half Year 2017 Financial Results On August 24, 2017 August 16, 2017
Certara Corporation Releases New Version Of D360, Its Industry-Leading Informatics Platform For Pharma Discovery Scientists January 30, 2017
